Literature DB >> 25156361

Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms.

Trevor R F Smith1, Gregory Verdeil1, Kristi Marquardt1, Linda A Sherman2.   

Abstract

Peripheral tolerance mechanisms are in place to prevent T cells from mediating aberrant immune responses directed against self and environmental Ags. Mechanisms involved in the induction of peripheral tolerance include T cell-intrinsic pathways, such as anergy or deletion, or exogenous tolerance mediated by regulatory T cells. We have previously shown that the density of peptide-MHC class I recognized by the TCR determines whether CD8(+) T cells undergo anergy or deletion. Specifically, using a TCR-transgenic CD8(+) T cell model, we demonstrated that persistent peripheral exposure to low- or high-dose peptides in the absence of inflammatory signals resulted in clonal deletion or anergy of the T cell, respectively. In this study, by altering the affinity of the peptide-MHC tolerogen for TCR, we have confirmed that this mechanism is dependent on the level of TCR signaling that the CD8(+) T cell receives. Using altered peptide ligands (APLs) displaying high TCR affinities, we show that increasing the TCR signaling favors anergy induction. Conversely, using APLs displaying a decreased TCR affinity tilted our system in the direction of deletional tolerance. We demonstrate how differential peripheral CD8(+) T cell tolerance mechanisms are controlled by both the potency and density of MHC class I-peptide tolerogen.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156361      PMCID: PMC4170000          DOI: 10.4049/jimmunol.1401194

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands.

Authors:  S M Alam; G M Davies; C M Lin; T Zal; W Nasholds; S C Jameson; K A Hogquist; N R Gascoigne; P J Travers
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

2.  In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.

Authors:  David J Morgan; C Thomas Nugent; Benjamin J E Raveney; Linda A Sherman
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

3.  Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo.

Authors:  William L Redmond; Boris C Marincek; Linda A Sherman
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

4.  Inhibition of naïve class I-restricted T cells by altered peptide ligands.

Authors:  C Koniaras; F R Carbone; W R Heath; A M Lew
Journal:  Immunol Cell Biol       Date:  1999-08       Impact factor: 5.126

5.  The fate of low affinity tumor-specific CD8+ T cells in tumor-bearing mice.

Authors:  Michael A Lyman; C Thomas Nugent; Kristi L Marquardt; Judith A Biggs; Eric G Pamer; Linda A Sherman
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

6.  Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells.

Authors:  K A Hogquist; S C Jameson; M J Bevan
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

7.  The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.

Authors:  S P Cobbold; G Martin; H Waldmann
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

8.  Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells.

Authors:  W Li; C D Whaley; A Mondino; D L Mueller
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

9.  Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance.

Authors:  B Rocha; A Grandien; A A Freitas
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.

Authors:  D R DeSilva; W S Feeser; E J Tancula; P A Scherle
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Targeting cancer-specific mutations by T cell receptor gene therapy.

Authors:  Thomas Blankenstein; Matthias Leisegang; Wolfgang Uckert; Hans Schreiber
Journal:  Curr Opin Immunol       Date:  2015-02-27       Impact factor: 7.486

2.  Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.

Authors:  Christopher D Zahm; Viswa T Colluru; Douglas G McNeel
Journal:  Cancer Immunol Res       Date:  2017-06-20       Impact factor: 11.151

3.  PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization.

Authors:  Brian T Rekoske; Heath A Smith; Brian M Olson; Brett B Maricque; Douglas G McNeel
Journal:  Cancer Immunol Res       Date:  2015-06-03       Impact factor: 11.151

4.  Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

Authors:  Trevor Smith; Xiaotian Lin; Marielle Mello; Kristi Marquardt; Jocelyn Cheung; Binfeng Lu; Linda A Sherman; Grégory Verdeil
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

Review 5.  Regulatory circuits of T cell function in cancer.

Authors:  Daniel E Speiser; Ping-Chih Ho; Grégory Verdeil
Journal:  Nat Rev Immunol       Date:  2016-08-16       Impact factor: 53.106

Review 6.  Peptide vaccines in cancer-old concept revisited.

Authors:  Takumi Kumai; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Curr Opin Immunol       Date:  2016-12-09       Impact factor: 7.486

7.  Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms.

Authors:  Danilo Presotto; Efe Erdes; Minh Ngoc Duong; Mathilde Allard; Pierre-Olivier Regamey; Manfredo Quadroni; Marie-Agnès Doucey; Nathalie Rufer; Michael Hebeisen
Journal:  Front Immunol       Date:  2017-11-15       Impact factor: 7.561

8.  Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation.

Authors:  Cihan Tastan; Ece Karhan; Wei Zhou; Elizabeth Fleming; Anita Y Voigt; Xudong Yao; Lei Wang; Meghan Horne; Lindsey Placek; Lina Kozhaya; Julia Oh; Derya Unutmaz
Journal:  Mucosal Immunol       Date:  2018-08-16       Impact factor: 7.313

Review 9.  Immune Cells and Inflammation in Diabetic Nephropathy.

Authors:  Zihan Zheng; Feng Zheng
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

10.  Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro.

Authors:  Thomas M Schmitt; David H Aggen; Kumiko Ishida-Tsubota; Sebastian Ochsenreither; David M Kranz; Philip D Greenberg
Journal:  Nat Biotechnol       Date:  2017-11-06       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.